Literature DB >> 19868772

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

M Heidelberger1, O T Avery.   

Abstract

1. A method is given for the concentration and purification of the soluble specific substance of the pneumococcus. 2. The material obtained by this method is shown to consist mainly of a carbohydrate which appears to be a polysaccharide built up of glucose molecules. 3. Whether the soluble specific substance is actually the polysaccharide, or occurs merely associated with it, is still undecided, although the evidence points in the direction of the former possibility.

Entities:  

Year:  1923        PMID： 19868772      PMCID： PMC2128423          DOI： 10.1084/jem.38.1.73

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  2 in total

1.  FURTHER STUDIES ON BACTERIAL HYPERSUSCEPTIBILITY. II.

Authors:  H Zinsser; J T Parker
Journal:  J Exp Med       Date:  1923-01-31       Impact factor: 14.307

2.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307
  2 in total
  60 in total

1.  [A contribution to the serology of Bacterium bifidum].

Authors:  G MALYOTH; R VOGEL
Journal:  Klin Wochenschr       Date:  1952-12-01

2.  A sweet T cell response.

Authors:  Rino Rappuoli; Ennio De Gregorio
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

Review 3.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

4.  [Mechanical destruction and extraction of bacteria].

Authors:  H HEIN
Journal:  Z Hyg Infektionskr       Date:  1951

Review 5.  Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  Annu Rev Pathol       Date:  2016-02-25       Impact factor: 23.472

Review 6.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 7.  History of passive antibody administration for prevention and treatment of infectious diseases.

Authors:  Barney S Graham; Donna M Ambrosino
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

Review 8.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

9.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS.

Authors:  W S Tillett; T Francis
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

10.  THE IMMUNOLOGICAL RELATIONSHIPS OF STREPTOCOCCUS VIRIDANS AND CERTAIN OF ITS CHEMICAL FRACTIONS : I. SEROLOGICAL REACTIONS OBTAINED WITH ANTIBACTERIAL SERA.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.